Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Device deficiencies (N = 54)

From: Feasibility, reliability, usability, and satisfaction of a digital medical device (ZEMY) for symptom management in patients treated for breast cancer: a single-arm interventional study

 

Number of events

Number of patients (%)

All device deficiencies

95

37 (68.5%)

Device deficiency associated to an adverse device effect

0

0 (0.0%)

Device deficiency that could have led to an adverse event

0

0 (0.0%)

Device deficiency that led to an action taken with the device

14

11 (20.4%)